CLINICAL STAGE III GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for CLINICAL STAGE III GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new CLINICAL STAGE III GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for CLINICAL STAGE III GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo tested to fight advanced GI cancers

Disease control Recruiting now

This early-stage study aims to find the safest and most effective dose of a new two-drug combination for people with advanced colorectal or gastroesophageal (stomach/esophagus) cancers that have spread. The trial will enroll about 45 adults whose cancer has progressed after at le…

Matched conditions: CLINICAL STAGE III GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

CLINICAL STAGE III GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new CLINICAL STAGE III GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New drug duo tested to fight advanced GI cancers